Jeremy Blum


Jeremy is an contentious IP specialist who focuses on trade mark, design and copyright issues. He has a wide experience in providing advice in relation to pharmaceutical trade marks and also assists clients with obtaining naming approval from the EMA. He has a broad understanding of the pharma industry having acted for the defendant in a large damages claim made as a result of a cross undertaking as to damages for a preliminary injunction preventing the launch of a generic product. He often advises clients on anti-counterfeiting strategies and novel tools to prevent infringement online.